Home › All Companies › USNA

USANA HEALTH SCIENCES INC (USNA)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-01-08

Key Insights

  • USANA Health Sciences announced a leadership transition, with co-founder Kevin Guest reassuming the role of CEO after Jim Brown stepped down.
  • The compensation arrangements for the departing CEO and incoming CEO are still being determined by the Compensation Committee and will be disclosed in a future filing.
  • Kevin Guest has a long history with USANA, having held various executive roles since joining the company in 2003 and previously serving as CEO from 2015-2016.
Sentiment: Neutral Significance: 6/10
View Original Filing →

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.